β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition.
- DOI
- 10.1016/j.bcp.2026.118459
- Published
- 2026 Sep 9
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118459,
title = {β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition.},
author = {Zhang X and Wang C and Xie Y and Kang X and Du M and Chen X and Jiang Z and Yan B},
year = {2026},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2026.118459},
url = {https://doi.org/10.1016/j.bcp.2026.118459}
}RIS
TY - JOUR TI - β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition. AU - Zhang X AU - Wang C AU - Xie Y AU - Kang X AU - Du M AU - Chen X AU - Jiang Z AU - Yan B PY - 2026 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2026.118459 UR - https://doi.org/10.1016/j.bcp.2026.118459 ER -
APA
X, Z., C, W., Y, X., X, K., M, D., X, C., Z, J., & B, Y. (2026). β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118459
Source records
- pubmed · retrieved 2026-09-25T05:00:25.193Z